Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach

British Journal of Cancer

Volumn 106, Issue 10, 2012, Pages 1668-1674

  Yoshii, M ^a   Tanaka, H ^a   Ohira, M ^a   Muguruma, K ^a   Iwauchi, T ^a   Lee, T ^a   Sakurai, K ^a   Kubo, N ^a   Yashiro, M ^a   Sawada, T ^a   Hirakawa, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Metastasis; Signet ring cell carcinoma

Indexed keywords

GALECTIN 1; INDOLEAMINE 2,3 DIOXYGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TUMOR IMMUNITY;

CARCINOMA, SIGNET RING CELL; CELL LINE, TUMOR; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; RNA, MESSENGER; STOMACH NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 84860766933     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.141     Document Type: Article

References (28)

1. Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Gobel G, Margreiter R, Konigsrainer A, Fuchs D, Amberger A (2006) Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 12: 1144-1151 (Pubitemid 43342502)
2. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998 (Pubitemid 35363648)
3. Ebert LM, Tan BS, Browning J, Svobodova S, Russell SE, Kirkpatrick N, Gedye C, Moss D, Ng SP, MacGregor D, Davis ID, Cebon J, Chen W (2008) The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 68: 3001-3009 (Pubitemid 351556301)
4. Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI (2007) Galectin-1: a key effector of regulation mediated by CD4+ CD25+ T cells. Blood 109: 2058-2065 (Pubitemid 46348206)
5. Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grussel S, Sipos B, Grutzmann R, Pilarsky C, Ungefroren H, Saeger HD, Kloppel G, Kabelitz D, Kalthoff H (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67: 8344-8350 (Pubitemid 47395173)
6. Hyung WJ, Noh SH, Lee JH, Huh JJ, Lah KH, Choi SH, Min JS (2002) Early gastric carcinoma with signet ring cell histology. Cancer 94: 78-83 (Pubitemid 34049044)
7. Ino K, Yamamoto E, Shibata K, Kajiyama H, Yoshida N, Terauchi M, Nawa A, Nagasaka T, Takikawa O, Kikkawa F (2008) Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumorinfiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Clin Cancer Res 14: 2310-2317 (Pubitemid 351551062)
8. Ino K, Yoshida N, Kajiyama H, Shibata K, Yamamoto E, Kidokoro K, Takahashi N, Terauchi M, Nawa A, Nomura S, Nagasaka T, Takikawa O, Kikkawa F (2006) Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer 95: 1555-1561 (Pubitemid 44863359)
9. Kubach J, Lutter P, Bopp T, Stoll S, Becker C, Huter E, Richter C, Weingarten P, Warger T, Knop J, Mullner S, Wijdenes J, Schild H, Schmitt E, Jonuleit H (2007) Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110: 1550-1558 (Pubitemid 47443971)
10. Kuo PL, Hung JY, Huang SK, Chou SH, Cheng DE, Jong YJ, Hung CH, Yang CJ, Tsai YM, Hsu YL, Huang MS (2011) Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway. J Immunol 186: 1521-1530
11. Li C, Kim S, Lai JF, Hyung WJ, Choi WH, Choi SH, Noh SH (2007) Advanced gastric carcinoma with signet ring cell histology. Oncology 72: 64-68 (Pubitemid 350249131)
12. Maehara Y, Tomisaki S, Oda S, Kakeji Y, Tsujitani S, Ichiyoshi Y, Akazawa K, Sugimachi K (1997) Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. Int J Cancer 74: 224-228 (Pubitemid 27234515)
13. Mansfield AS, Heikkila PS, Vaara AT, von Smitten KA, Vakkila JM, Leidenius MH (2009) Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 9: 231
14. Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H (2008) Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 98: 148-153
15. Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, Saito S (2007) Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 98: 874-881 (Pubitemid 46691826)
16. Polak ME, Borthwick NJ, Gabriel FG, Johnson P, Higgins B, Hurren J, McCormick D, Jager MJ, Cree IA (2007) Mechanisms of local immunosuppression in cutaneous melanoma. Br J Cancer 96: 1879-1887 (Pubitemid 46912012)
17. Rabinovich GA (2005) Galectin-1 as a potential cancer target. Br J Cancer 92: 1188-1192 (Pubitemid 40604390)
18. Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A, Mordoh J, Fainboim L, Podhajcer OL, Rabinovich GA (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumorimmune privilege. Cancer Cell 5: 241-251 (Pubitemid 38402116)
19. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500
20. Shen Z, Zhou S, Wang Y, Li RL, Zhong C, Liang C, Sun Y (2010) Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3 +CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 136: 1585-1595
21. Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645
22. Shu S, Cochran AJ, Huang RR, Morton DL, Maecker HT (2006) Immune responses in the draining lymph nodes against cancer: implications for immunotherapy. Cancer Metastasis Rev 25: 233-242 (Pubitemid 43886398)
23. Smith EL, Finney HM, Nesbitt AM, Ramsdell F, Robinson MK (2006) Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology 119: 203-211 (Pubitemid 44401639)
24. Wan YY, Flavell RA (2008) TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 28: 647-659
25. Wang LH, Su L, Wang JT (2010a) Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer. Chinese Med J 123: 3545-3549
26. Wang WH, Jiang CL, Yan W, Zhang YH, Yang JT, Zhang C, Yan B, Zhang W, Han W, Wang JZ, Zhang YQ (2010b) FOXP3 expression and clinical characteristics of hepatocellular carcinoma. World J Gastroenterol 16: 5502-5509
27. Yashiro M, Chung YS, Kubo T, Hato F, Sowa M (1996) Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. Br J Cancer 74: 1096-1103 (Pubitemid 26333913)
28. Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6: 295-307